PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; Mildred Scheel School of Oncology, University Hospital Bonn, Medical Faculty, 53127 Bonn, Germany.\', \'Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; Unit of Experimental Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.\', \'Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; Institute of Immunology, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.\', \'Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.\', \'Institute for Immunology, Technische Universität Dresden, Medical Faculty Carl Gustav Carus, 01307 Dresden, Germany. Electronic address: rayk.behrendt@tu-dresden.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0163-7258(21)00133-910.1016/j.pharmthera.2021.107931
?:hasPublicationType
?:journal
  • Pharmacology & therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34171328
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all